$6.81
À la fermeture: Nov 3 EDT
$6.85
0.040.59%
Pré-commercialisation: 7:50 PM EDT
Suivez les dernières activités de délit d'initié Bausch Health Companies. Restez informé des achats, des ventes et de l'impact sur le marché des actions Bausch Health Companies.
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Les initiés n’ont signalé aucun achat/vente au cours des 30 derniers jours.
Sep 08, 2025  | EVP, GENERAL COUNSEL  | -64.71K  | $7.34  | -$475.06K  | SELL  | -11.47%  | 499.58K  | Sep 05 - Sep 08  | ||
Aug 22, 2025  | DIRECTOR  | -15.91K  | $7.66  | -$121.89K  | SELL  | -17.74%  | 73.80K  | Aug 21  | ||
Aug 14, 2025  | —  | 34.72M  | $9.00  | $312.49M  | BUY  | 96.35%  | 70.76M  | Aug 14  | ||
Aug 13, 2025  | —  | 3.24M  | $6.56  | $21.27M  | BUY  | 9.89%  | 36.03M  | Aug 11 - Aug 13  | ||
Jun 17, 2025  | —  | 3.56M  | $5.94  | $21.17M  | BUY  | 12.19%  | 32.79M  | Jun 13  | ||
Jun 12, 2025  | —  | 2.79M  | $5.27  | $14.70M  | BUY  | 10.55%  | 29.23M  | Jun 10 - Jun 12  | ||
Dec 03, 2024  | EVP, GENERAL COUNSEL  | -2.13K  | $8.37  | -$17.84K  | SELL  | -0.49%  | 433.07K  | Nov 29 - Dec 02  | ||
Sep 09, 2024  | EVP, GENERAL COUNSEL  | -64.71K  | $6.19  | -$400.80K  | SELL  | -12.94%  | 435.20K  | Sep 05 - Sep 06  | ||
Mar 04, 2024  | EVP, GENERAL COUNSEL  | 116.98K  | $9.87  | -$301.63K  | GRANT  | 30.55%  | 499.90K  | Feb 29 - Mar 04  | ||
Dec 05, 2023  | EVP, GENERAL COUNSEL  | -1.91K  | $7.36  | -$14.07K  | SELL  | -0.50%  | 382.93K  | Dec 01 - Dec 05  | ||
Nov 06, 2023  | EVP, GENERAL COUNSEL  | -377.00  | $7.57  | -$2.86K  | SELL  | -0.10%  | 384.84K  | Nov 03 - Nov 06  | ||
Sep 06, 2023  | EVP, GENERAL COUNSEL  | -58.02K  | $8.34  | -$484.02K  | SELL  | -13.09%  | 385.21K  | Sep 05 - Sep 06  | ||
Mar 01, 2023  | EVP, GENERAL COUNSEL  | -2.53K  | $9.54  | -$24.18K  | SELL  | -0.70%  | 359.19K  | Feb 27 - Feb 28  | ||
Apr 15, 2022  | U.S. PRESIDENT-PHARMA BUSINESS  | -1.59K  | $22.19  | -$35.39K  | SELL  | -1.73%  | 90.51K  | Apr 14  | ||
Mar 16, 2022  | U.S. PRESIDENT-PHARMA BUSINESS  | -4.85K  | $22.20  | -$107.58K  | SELL  | -5.00%  | 92.10K  | Mar 15  | ||
Mar 10, 2022  | PRES&CO-HEAD BAUSCH&LOMB/INT'L  | -3.89K  | $21.76  | -$84.62K  | SELL  | -4.01%  | 93.14K  | Mar 08  | ||
Mar 04, 2022  | PRES&CO-HEAD BAUSCH&LOMB/INT'L  | -11.08K  | $23.37  | -$258.87K  | SELL  | -9.87%  | 101.10K  | Mar 02  | ||
Mar 04, 2022  | U.S. PRESIDENT-PHARMA BUSINESS  | 34.03K  | $23.77  | $823.83K  | GRANT  | 50.80%  | 101.02K  | Mar 02  | ||
Mar 02, 2022  | PRES&CO-HEAD BAUSCH&LOMB/INT'L  | 1.54K  | $24.14  | -$381.59K  | SELL-OPTIONS  | 1.39%  | 112.18K  | Feb 26 - Mar 01  | ||
Feb 17, 2022  | U.S. PRESIDENT-PHARMA BUSINESS  | -3.25K  | $25.02  | -$81.34K  | SELL  | -5.12%  | 60.30K  | Feb 15  | ||
Jan 20, 2022  | U.S. PRESIDENT-PHARMA BUSINESS  | -3.25K  | $26.63  | -$86.57K  | SELL  | -4.87%  | 63.55K  | Jan 18  | ||
Dec 02, 2021  | DIRECTOR  | 60.00K  | $24.23  | $1.45M  | BUY  | ∞  | 10.00K  | Nov 30  | ||
Aug 09, 2021  | DIRECTOR  | 1.40K  | $25.94  | $36.32K  | BUY  | 3.76%  | 38.65K  | Aug 05  | ||
Aug 06, 2021  | DIRECTOR  | 10.00K  | $25.01  | $250.12K  | BUY  | 3.12%  | 330.91K  | Aug 04  | ||
Jun 15, 2021  | EVP & CHIEF FINANCIAL OFFICER  | -17.00K  | $31.68  | -$538.59K  | SELL  | -12.70%  | 116.86K  | Jun 11  | ||
Jun 04, 2021  | EVP AND GENERAL COUNSEL  | 0.00  | $23.34  | -$2.06M  | SELL-OPTIONS  | 0.00%  | 166.76K  | Jun 02  | ||
May 28, 2021  | DIRECTOR  | -11.04K  | $31.79  | -$350.81K  | SELL  | -10.09%  | 98.33K  | May 26  | ||
Dec 08, 2020  | —  | 0.00  | $17.13  | -$626.29K  | OPTION EXERCISE  | 0.00%  | 235.03K  | Dec 04  | ||
Nov 30, 2020  | —  | 0.00  | $17.01  | -$193.28K  | OPTION EXERCISE  | 0.00%  | 235.03K  | Nov 23 - Nov 27  | 
Parcourir transactions d'initiés sur toutes les actions.